{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T16:33:19Z","timestamp":1777480399985,"version":"3.51.4"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T00:00:00Z","timestamp":1653436800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T00:00:00Z","timestamp":1653436800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Among the histiocytic disorders, anaplastic lymphoma kinase (ALK)-positive histiocytosis emerged in 2008. As more and more cases of the novel entity are reported, our understanding of it is deepened. However, only a few cases with central nervous system (CNS) involvement have been reported. Furthermore, the lesion in the suprasellar region has\u00a0not\u00a0been\u00a0documented.\u00a0<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>We presented a case of ALK-positive histiocytosis involving the suprasellar region of a one-year-and-four-month-old boy. Through clinical, neuropathological, and genomic analyses, the patient was diagnosed with ALK-positive histiocytosis. After lesions were resected he started treatment with a combination of the three compounds vincristine, prednisolone, and crizotinib, but they did not work. Cytarabine was then added as an additional chemotherapy drug for him, and the lesions in the brain and lungs were shrunk by combining treatment of crizotinib, dexamethasone, vincristine, and cytarabine according to the RECIST (esponse Evaluation Criteria In Solid Tumours).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Additional adjuvant chemotherapy drugs are needed when ALK-inhibitor treatment is ineffective.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12887-022-03368-1","type":"journal-article","created":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T08:04:04Z","timestamp":1653465844000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Failure of crizotinib based systemic treatment in ALK positive histiocytosis involving the central nervous system: a case report and literature review"],"prefix":"10.1186","volume":"22","author":[{"given":"Qiang","family":"He","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,5,25]]},"reference":[{"issue":"7","key":"3368_CR1","doi-asserted-by":"publisher","first-page":"2965","DOI":"10.1182\/blood-2008-03-147017","volume":"112","author":"JK Chan","year":"2008","unstructured":"Chan JK, Lamant L, Algar E, Delsol G, Tsang WY, Lee KC, et al. ALK+ histiocytosis: a novel type of systemic histiocytic proliferative disorder of early infancy. Blood. 2008;112(7):2965\u20138.","journal-title":"Blood"},{"issue":"5","key":"3368_CR2","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1038\/s41379-018-0168-6","volume":"32","author":"KTE Chang","year":"2019","unstructured":"Chang KTE, Tay AZE, Kuick CH, Chen H, Algar E, Taubenheim N, et al. ALK-positive histiocytosis: an expanded clinicopathologic spectrum and frequent presence of KIF5B-ALK fusion. Mod Pathol. 2019;32(5):598\u2013608.","journal-title":"Mod Pathol"},{"issue":"2","key":"3368_CR3","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s00401-019-02027-7","volume":"138","author":"CG Lucas","year":"2019","unstructured":"Lucas CG, Gilani A, Solomon DA, Liang X, Maher OM, Chamyan G, et al. ALK-positive histiocytosis with KIF5B-ALK fusion in the central nervous system. Acta Neuropathol. 2019;138(2):335\u20137.","journal-title":"Acta Neuropathol"},{"issue":"5","key":"3368_CR4","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1177\/1066896920976862","volume":"29","author":"TAN Tran","year":"2021","unstructured":"Tran TAN, Chang KTE, Kuick CH, Goh JY, Chang CC. Local ALK-Positive Histiocytosis With Unusual Morphology and Novel TRIM33-ALK Gene Fusion. Int J Surg Pathol. 2021;29(5):543\u20139.","journal-title":"Int J Surg Pathol"},{"issue":"3","key":"3368_CR5","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1097\/PAS.0000000000001567","volume":"45","author":"J Kashima","year":"2021","unstructured":"Kashima J, Yoshida M, Jimbo K, Izutsu K, Ushiku T, Yonemori K, et al. ALK-positive Histiocytosis of the Breast: A Clinicopathologic Study Highlighting Spindle Cell Histology. Am J Surg Pathol. 2021;45(3):347\u201355.","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"3368_CR6","doi-asserted-by":"publisher","first-page":"e534","DOI":"10.3324\/haematol.2019.230094","volume":"104","author":"GK Gupta","year":"2019","unstructured":"Gupta GK, Xi L, Pack SD, Jones JB, Pittaluga S, Raffeld M, et al. ALK-positive histiocytosis with KIF5B-ALK fusion in an adult female. Haematologica. 2019;104(11):e534\u20136.","journal-title":"Haematologica"},{"issue":"5","key":"3368_CR7","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1080\/10428194.2020.1861273","volume":"62","author":"L Qiu","year":"2021","unstructured":"Qiu L, Weitzman SP, Nastoupil LJ, Williams MD, Medeiros LJ, Vega F. Disseminated ALK-positive histiocytosis with KIF5B-ALK fusion in an adult. Leuk Lymphoma. 2021;62(5):1234\u20138.","journal-title":"Leuk Lymphoma"},{"issue":"2","key":"3368_CR8","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1159\/000508524","volume":"144","author":"F Swain","year":"2021","unstructured":"Swain F, Williams B, Barbaro P. ALK-Positive Histiocytosis with Peripheral Blood Histiocytes: A Case Report. Acta Haematol. 2021;144(2):218\u201321.","journal-title":"Acta Haematol"},{"issue":"5","key":"3368_CR9","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1177\/1093526617740784","volume":"21","author":"H Huang","year":"2018","unstructured":"Huang H, Gheorghe G, North PE, Suchi M. Expanding the Phenotype of ALK-positive Histiocytosis: A Report of 2 Cases. Pediatr Dev Pathol. 2018;21(5):449\u201355.","journal-title":"Pediatr Dev Pathol"},{"issue":"2","key":"3368_CR10","first-page":"172","volume":"37","author":"OI Jaber","year":"2021","unstructured":"Jaber OI, Jarrah DA, Hiasat M, Hussaini MA. ALK-Positive Histiocytosis: A Case Report and Literature Review. Turk Patoloji Derg. 2021;37(2):172\u20137.","journal-title":"Turk Patoloji Derg"},{"key":"3368_CR11","doi-asserted-by":"crossref","unstructured":"Osako T, Kurisaki-Arakawa A, Dobashi A, Togashi Y, Baba S, Shiozawa S, et al. Distinct Clinicopathologic Features and Possible Pathogenesis of Localized ALK-positive Histiocytosis of the Breast. Am J Surg Pathol. 2021.","DOI":"10.1097\/PAS.0000000000001794"},{"issue":"9","key":"3368_CR12","doi-asserted-by":"publisher","first-page":"10095","DOI":"10.21037\/apm-21-2117","volume":"10","author":"Y Tian","year":"2021","unstructured":"Tian Y, Li J, Liu B, Xie H, Zheng M, Yao W. ALK-positive histiocytosis with disseminated disease responded to alectinib: a case report. Ann Palliat Med. 2021;10(9):10095\u2013101.","journal-title":"Ann Palliat Med"},{"issue":"6","key":"3368_CR13","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1007\/s00428-021-03092-8","volume":"479","author":"Y Bai","year":"2021","unstructured":"Bai Y, Sun W, Niu D, Yang X, Diao X, Yu Y, et al. Localized ALK-positive histiocytosis in a Chinese woman: report of a case in the lung with a novel EML4-ALK rearrangement. Virchows Arch. 2021;479(6):1079\u201383.","journal-title":"Virchows Arch"},{"issue":"2","key":"3368_CR14","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1182\/blood.2021013338","volume":"139","author":"PG Kemps","year":"2022","unstructured":"Kemps PG, Picarsic J, Durham BH, Helias-Rodzewicz Z, Hiemcke-Jiwa L, van den Bos C, et al. ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition. Blood. 2022;139(2):256\u201380.","journal-title":"Blood"},{"issue":"6","key":"3368_CR15","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1111\/nan.12739","volume":"47","author":"S Rossi","year":"2021","unstructured":"Rossi S, Gessi M, Barresi S, Tamburrini G, Giovannoni I, Ruggiero A, et al. ALK-rearranged histiocytosis: Report of two cases with involvement of the central nervous system. Neuropathol Appl Neurobiol. 2021;47(6):878\u201381.","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"2","key":"3368_CR16","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1158\/2159-8290.CD-15-0913","volume":"6","author":"EL Diamond","year":"2016","unstructured":"Diamond EL, Durham BH, Haroche J, Yao Z, Ma J, Parikh SA, et al. Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms. Cancer Discov. 2016;6(2):154\u201365.","journal-title":"Cancer Discov"},{"issue":"12","key":"3368_CR17","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1038\/s41591-019-0653-6","volume":"25","author":"BH Durham","year":"2019","unstructured":"Durham BH, Lopez Rodrigo E, Picarsic J, Abramson D, Rotemberg V, De Munck S, et al. Activating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasms. Nat Med. 2019;25(12):1839\u201342.","journal-title":"Nat Med"},{"issue":"12","key":"3368_CR18","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1634\/theoncologist.2016-0488","volume":"22","author":"JS Ross","year":"2017","unstructured":"Ross JS, Ali SM, Fasan O, Block J, Pal S, Elvin JA, et al. ALK Fusions in a Wide Variety of Tumor Types Respond to Anti-ALK Targeted Therapy. Oncologist. 2017;22(12):1444\u201350.","journal-title":"Oncologist"},{"issue":"1","key":"3368_CR19","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1242\/dev.114769","volume":"142","author":"MH Wilson","year":"2015","unstructured":"Wilson MH, Holzbaur EL. Nesprins anchor kinesin-1 motors to the nucleus to drive nuclear distribution in muscle cells. Development. 2015;142(1):218\u201328.","journal-title":"Development"},{"issue":"18","key":"3368_CR20","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1007\/s40265-013-0142-z","volume":"73","author":"JE Frampton","year":"2013","unstructured":"Frampton JE. Crizotinib: a review of its use in the treatment of anaplastic lymphoma kinase-positive, advanced non-small cell lung cancer. Drugs. 2013;73(18):2031\u201351.","journal-title":"Drugs"},{"issue":"4","key":"3368_CR21","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/S1470-2045(15)00614-2","volume":"17","author":"DW Kim","year":"2016","unstructured":"Kim DW, Mehra R, Tan DSW, Felip E, Chow LQM, Camidge DR, et al. Activity and safety of ceritinib in patients with ALK-rearranged non-small-cell lung cancer (ASCEND-1): updated results from the multicentre, open-label, phase 1 trial. Lancet Oncol. 2016;17(4):452\u201363.","journal-title":"Lancet Oncol"},{"issue":"1057","key":"3368_CR22","first-page":"e9","volume":"106","author":"Z Rossini","year":"2017","unstructured":"Rossini Z, Milani D, Costa F, Castellani C, Lasio G, Fornari M. Subdural Fluid Collection and Hydrocephalus After Foramen Magnum Decompression for Chiari Malformation Type I: Management Algorithm of a Rare Complication. World Neurosurg. 2017;106(1057):e9\u201315.","journal-title":"World Neurosurg"},{"issue":"3","key":"3368_CR23","doi-asserted-by":"publisher","first-page":"485","DOI":"10.3171\/jns.1998.88.3.0485","volume":"88","author":"Y Yoshimoto","year":"1998","unstructured":"Yoshimoto Y, Wakai S, Hamano M. External hydrocephalus after aneurysm surgery: paradoxical response to ventricular shunting. J Neurosurg. 1998;88(3):485\u20139.","journal-title":"J Neurosurg"},{"key":"3368_CR24","doi-asserted-by":"publisher","first-page":"743784","DOI":"10.1155\/2010\/743784","volume":"2010","author":"N Tzerakis","year":"2010","unstructured":"Tzerakis N, Orphanides G, Antoniou E, Sioutos PJ, Lafazanos S, Seretis A. Subdural effusions with hydrocephalus after severe head injury: successful treatment with ventriculoperitoneal shunt placement: report of 3 adult cases. Case Rep Med. 2010;2010:743784.","journal-title":"Case Rep Med"},{"issue":"1","key":"3368_CR25","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12893-019-0489-5","volume":"19","author":"R Wu","year":"2019","unstructured":"Wu R, Ye Y, Ma T, Jia G, Qin H. Management of subdural effusion and hydrocephalus following decompressive craniectomy for posttraumatic cerebral infarction in a patient with traumatic brain injury: a case report. BMC Surg. 2019;19(1):26.","journal-title":"BMC Surg"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-022-03368-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-022-03368-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-022-03368-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T08:05:29Z","timestamp":1653465929000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-022-03368-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,25]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["3368"],"URL":"https:\/\/doi.org\/10.1186\/s12887-022-03368-1","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,25]]},"assertion":[{"value":"9 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee on Biomedical Research, West China Hospital of Sichuan University. The patient\u2019s family provided written informed consent prior to the investigation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication was obtained from the parents of the patient. Our study complied with the CARE Checklist.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publication"}},{"value":"The authors declare that there is no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"308"}}